Volume 28, No 6, Jun 2018
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 28 Issue 6, June 2018: 690-692
LETTERS TO THE EDITOR
A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma
Cun Wang 1,2, Haojie Jin2, Dongmei Gao 3, Liqin Wang 1, Bastiaan Evers 1, Zheng Xue 1, Guangzhi Jin 4, Cor Lieftink 1,
Roderick L. Beijersbergen 1, Wenxin Qin 2 and René Bernards 1
1 Division of Molecular Carcinogenesis, Oncode Institute, Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute,
Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; 2 State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer
Institute, Renji Hospital, Shanghai Jiao Tong University School of
Medicine, Shanghai 200032, China; 3 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of
Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai
200032, China and 4 Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China
These authors contributed equally: Cun Wang, Haojie Jin, and
Dongmei Gao.
Correspondence: Wenxin Qin (wxqin@sjtu.edu.cn) or René Bernards(r.bernards@nki.nl)
10.1038/s41422-018-0020-z
FULL TEXT | PDF
Browse 1041
